An in-depth look to PANGEN BIOTECH INC. operating, investing, and financing activities

222110 free cash flow for Q3 24 is 770.03 M KRW. For 2023, 222110 free cash flow was -3.87 B KRW and operating cash flow was -3.45 B KRW.